Picard Medical Statistics
Total Valuation
Picard Medical has a market cap or net worth of $173.20 million. The enterprise value is $172.47 million.
| Market Cap | 173.20M |
| Enterprise Value | 172.47M |
Important Dates
The last earnings date was Friday, November 14, 2025, before market open.
| Earnings Date | Nov 14, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
Picard Medical has 73.70 million shares outstanding. The number of shares has increased by 149.19% in one year.
| Current Share Class | 73.70M |
| Shares Outstanding | 73.70M |
| Shares Change (YoY) | +149.19% |
| Shares Change (QoQ) | +517.47% |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | 0.73% |
| Float | 26.14M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 9.84 |
| Forward PS | n/a |
| PB Ratio | 21.92 |
| P/TBV Ratio | 25.60 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 36.18 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 2.16, with a Debt / Equity ratio of 0.08.
| Current Ratio | 2.16 |
| Quick Ratio | 0.74 |
| Debt / Equity | 0.08 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -2.03 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | -67.32% |
| Return on Invested Capital (ROIC) | -173.45% |
| Return on Capital Employed (ROCE) | -169.69% |
| Revenue Per Employee | $63,560 |
| Profits Per Employee | -$429,600 |
| Employee Count | 75 |
| Asset Turnover | 0.37 |
| Inventory Turnover | 0.72 |
Taxes
In the past 12 months, Picard Medical has paid $16,000 in taxes.
| Income Tax | 16,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
| Beta (5Y) | n/a |
| 52-Week Price Change | n/a |
| 50-Day Moving Average | 6.91 |
| 200-Day Moving Average | n/a |
| Relative Strength Index (RSI) | 29.57 |
| Average Volume (20 Days) | 2,397,671 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Picard Medical had revenue of $4.77 million and -$32.22 million in losses. Loss per share was -$1.63.
| Revenue | 4.77M |
| Gross Profit | -479,000 |
| Operating Income | -13.83M |
| Pretax Income | -31.53M |
| Net Income | -32.22M |
| EBITDA | -13.66M |
| EBIT | -13.83M |
| Loss Per Share | -$1.63 |
Balance Sheet
The company has $2.81 million in cash and $616,000 in debt, giving a net cash position of $2.20 million or $0.03 per share.
| Cash & Cash Equivalents | 2.81M |
| Total Debt | 616,000 |
| Net Cash | 2.20M |
| Net Cash Per Share | $0.03 |
| Equity (Book Value) | 7.97M |
| Book Value Per Share | 0.11 |
| Working Capital | 6.22M |
Cash Flow
| Operating Cash Flow | -14.45M |
| Capital Expenditures | n/a |
| Free Cash Flow | -14.45M |
| FCF Per Share | -$0.20 |
Margins
| Gross Margin | -10.05% |
| Operating Margin | -290.04% |
| Pretax Margin | -661.49% |
| Profit Margin | n/a |
| EBITDA Margin | -286.57% |
| EBIT Margin | -290.04% |
| FCF Margin | n/a |
Dividends & Yields
Picard Medical does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -149.19% |
| Shareholder Yield | -149.19% |
| Earnings Yield | -18.45% |
| FCF Yield | -8.27% |
Analyst Forecast
| Price Target | n/a |
| Price Target Difference | n/a |
| Analyst Consensus | n/a |
| Analyst Count | n/a |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 3 |